Emerging infectious diseases · 2011 · 167 citations · 32 references
Veterinary MedicineInfectious Disease ControlInfectious DiseasesClinical EpidemiologyEpidemiologyMedical MicrobiologyBacterial EpidemiologyBacterial InfectionsBacterial ToxinsInfectious Disease Risk FactorsSusceptibility To InfectionToxin-mediated PathogenesisA-b ToxinsBacterial Toxin EpidemiologyBinary ToxinsClostridial InfectionsMicrobial ToxinsToxin GenesUnivariate AnalysisUnivariate Risk Analysis
We compared 30-day case-fatality rates for patients infected with Clostridium difficile possessing genes for toxins A and B without binary toxin (n = 212) with rates for patients infected with C. difficile possessing genes for A, B, and binary toxin. The latter group comprised patients infected with strains of PCR ribotype 027 (CD027, n = 193) or non-027 (CD non-027, n = 72). Patients with binary toxin had higher case-fatality rates than patients without binary toxin, in univariate analysis (relative risk [RR] 1.8, 95% confidence interval [CI] 1.2-2.7) and multivariate analysis after adjustment for age, sex, and geographic region (RR 1.6, 95% CI 1.0-2.4). Similar case-fatality rates (27.8%, 28.0%) were observed for patients infected with CD027 or CD non-027. Binary toxin either is a marker for more virulent C. difficile strains or contributes directly to strain virulence. Efforts to control C. difficile infection should target all virulent strains irrespective of PCR ribotype.
32
Glucosylation of Rho proteins by Clostridium difficile toxin B
Ingo Just, Jörg Selzer, Matthias Wilm et al. · Nature · 1995 · 1K citations
The role of toxin A and toxin B in Clostridium difficile infection
Sarah A. Kuehne, Stephen T. Cartman, John Heap et al. · Nature · 2010 · 875 citations